Early Circulating Tumor DNA Dynamics Predict Neoadjuvant Therapy Response and Recurrence in Colorectal Liver Metastases: A Prospective Study.

Xiang-Yu WangRui ZhangJia-Hao HanShi-Qing ChenFei-Long ZhaoHui ChenJing LinJie FanWen-Wei ZhuLu LuXiang-Yu Wang

Published in: Annals of surgical oncology (2023)

For CRLM patients receiving NAT, an early ctDNA change is a superior predictor of treatment response and recurrence compared with conventional tumor markers.

Keyphrases

circulating tumor
liver metastases
cell free
circulating tumor cells
free survival
rectal cancer
lymph node
locally advanced
stem cells
smoking cessation